PERITONEAL NEOPLASMS
Clinical trials for PERITONEAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL NEOPLASMS trials appear
Sign up with your email to follow new studies for PERITONEAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ovarian cancer: phase 3 trial tests targeted drug against Tough-to-Treat tumors
Disease control Recruiting nowThis large Phase 3 study tests a new medicine called Sofetabart Mipitecan for people with ovarian, fallopian tube, or peritoneal cancer. It includes two groups: those whose cancer stopped responding to platinum chemotherapy within six months (platinum-resistant), and those whose …
Matched conditions: PERITONEAL NEOPLASMS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail aims to fight tough gynecological cancers
Disease control Recruiting nowThis study tests a drug called relacorilant, taken as a pill, combined with two standard chemotherapy drugs (nab-paclitaxel and bevacizumab) in people with ovarian, fallopian tube, peritoneal, or endometrial cancers. The goal is to see if the combination can slow cancer growth or…
Matched conditions: PERITONEAL NEOPLASMS
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a simple protein improve recovery from heated chemo surgery?
Disease control Recruiting nowThis study tests whether adding a protein called albumin to standard IV fluids during a major cancer surgery (cytoreduction with heated chemotherapy) can reduce complications. 140 adults undergoing this surgery will be randomly assigned to receive either standard fluids or standa…
Matched conditions: PERITONEAL NEOPLASMS
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a common breast cancer drug keep ovarian cancer at bay?
Disease control Recruiting nowThis Phase 3 trial is testing whether adding letrozole (a hormone-blocking drug) to standard maintenance therapy can delay cancer recurrence in people with estrogen-receptor-positive ovarian cancer. About 540 participants who have completed initial surgery and chemotherapy will r…
Matched conditions: PERITONEAL NEOPLASMS
Phase: PHASE3 • Sponsor: Swiss GO Trial Group • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC